Impact of trigger-day serum luteinizing hormone levels on embryo quality and pregnancy outcomes in overweight and obese women undergoing GnRH antagonist protocols: a retrospective cohort study - Scorecard - MDSpire
Advertisement
Impact of trigger-day serum luteinizing hormone levels on embryo quality and pregnancy outcomes in overweight and obese women undergoing GnRH antagonist protocols: a retrospective cohort study
Clinical Scorecard: Influence of Serum Luteinizing Hormone Levels on Embryo Quality and Pregnancy Success in Overweight and Obese Women Undergoing GnRH Antagonist Protocols: A Retrospective Analysis
At a Glance
Category
Detail
Condition
Key Mechanisms
Luteinizing hormone (LH) impacts follicular development and IVF outcomes; obesity affects LH secretion and ovarian response.
Target Population
Care Setting
Key Highlights
Elevated trigger-day LH levels correlate with poorer ovarian response and embryo quality.
No significant differences in clinical pregnancy or live birth rates among LH groups, but further clarification needed.
Higher LH levels negatively impact follicle and embryo quality in overweight women.
Guideline-Based Recommendations
Diagnosis
Management
Monitoring & Follow-up
Monitor ovarian response and embryo quality in relation to LH levels, including specific LH thresholds.
Risks
Patient & Prescribing Data
Higher doses of gonadotropins may be required, but outcomes remain lower compared to normal-weight counterparts; consider potential side effects.
Clinical Best Practices
Maintain LH within an optimal window during IVF cycles, considering patient-specific factors.
In a target-trial emulation of more than 600,000 veterans, GLP-1 RA initiators saw fewer new substance use disorders—and patients with existing SUDs had fewer overdoses, hospitalizations, and deaths.
